DCLK3

Chr 3

doublecortin like kinase 3

Also known as: CLR, DCAMKL3, DCDC3C, DCK3

Predicted to enable protein serine/threonine kinase activity. Predicted to be involved in intracellular signal transduction. Predicted to act upstream of or within negative regulation of protein localization to nucleus and peptidyl-serine phosphorylation. Predicted to be active in cytoplasm and nucleus. [provided by Alliance of Genome Resources, Jun 2026]

OMIMResearchGenerating clinical summary…

Clinical highlights

Interpreting a novel variant
This gene is strongly intolerant of loss-of-function variation in the population, so LoF variants warrant close attention. No curated mechanism annotation is available — see the mechanism card for the computational prediction and its caveats.Based on population constraint only.
0
Active trials
8
Pubs (1 yr)
—
P/LP submissions
—
P/LP missense
0.56
LOEUF
Multiple*
Mechanism· predicted

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Moderate LoF intolerance
LoF Constraint?
0.56LOEUF
pLI 0.137
Z-score 2.93
OE 0.27 (0.14–0.56)
Moderately constrained

More LoF-intolerant than ~75% of genes

Missense Constraint?
0.80Z-score
OE missense 0.88 (0.80–0.97)
317 obs / 359.6 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios?
LoF OE?0.27 (0.14–0.56)
0≤0.351.4
Missense OE?0.88 (0.80–0.97)
0≤0.61.4
Synonymous OE?1.10
0≤1.21.6
LoF obs/exp: 5 / 18.7Missense obs/exp: 317 / 359.6Syn Z: -0.90

ClinVar Variant Classifications

0 submitted variants in ClinVar

Protein Context — Lollipop Plot

DCLK3 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →